This announcement details that the SZSE Listing Review Center has approved the company's application to issue shares to specific objects. The company meets the issuance and listing conditions and disclosure requirements. The application will now be submitted to the CSRC for registration, with the final approval and timing remaining uncertain. Investors are advised to be aware of investment risks.
Summary generated by AI · Always verify with source document
Securities Code: 300149 Securities Abbreviation: Ruizhi Medicine Announcement No.: 2026-40
Ruizhi Medicine Technology Co., Ltd.
Announcement on Shenzhen Stock Exchange Listing Review Center's Approval of Application for Issuance of Shares to Specific Objects
The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and contains no false records, misleading statements, or major omissions.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.